The US Oncology (US Oncology) Network has grown its network of independent physicians from 1,200 at year-end 2019 to more than 1,350 currently.
US Oncology helps independent physicians deliver value-based, integrated care to patients. US Oncology provides practices with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Corporation.
US Oncology recently added two new physician-owned practices, Alliance Cancer Specialists and Northwest Oncology.
Alliance Cancer Specialists serves patients in Southeastern Pennsylvania, with 21 board-certified medical oncologists and hematologists, eight advanced practice providers and approximately 160 employees who serve patients and referring physicians in the Delaware Valley from 10 sites of service.
Northwest Oncology is an integrative healthcare center specializing in the diagnosis, treatment and support of patients with oncolytic and hematological disorders. The practice is an advanced oncology group in Northwest Indiana with eight physicians and a team of more than 40 support staff members who provide medical oncology, hematology and gynecologic oncology services from two locations.
McKesson acquired US Oncology in 2010 to leverage its infrastructure and broader set of services across a larger segment of the market by delivering increased value to its pharmaceutical manufacturers. The acquisition built upon McKesson’s 2007 acquisition of Oncology Therapeutics Network.
US Oncology offers two models to independent oncology practices:
- Comprehensive Strategic Alliance – physicians maintain their independence, but receive the support of US Oncology as a management company.
- Joint Venture Model – practices and US Oncology focus on the management of a radiation oncology center.
Takeaway: US Oncology extends its national footprint as McKesson strengthens its preferred supply relationship for drug distribution